EFFECTS OF EPIDERMAL GROWTH-FACTOR ON THE TYROSINE PHOSPHORYLATION OFMITOGEN-ACTIVATED PROTEIN-KINASES IN MONOLAYER-CULTURES OF PORCINE GRANULOSA-CELLS
Ba. Keel et al., EFFECTS OF EPIDERMAL GROWTH-FACTOR ON THE TYROSINE PHOSPHORYLATION OFMITOGEN-ACTIVATED PROTEIN-KINASES IN MONOLAYER-CULTURES OF PORCINE GRANULOSA-CELLS, Endocrinology, 136(3), 1995, pp. 1197-1204
We have examined porcine granulosa cells (pGCs) for the presence of im
munodetectable mitogen-activated protein (MAP) kinases (extracellular
signal-regulated kinases, ERK) and have further studied the effects of
epidermal growth factor (EGF) an the activation of these kinases. Cel
l lysates prepared from untreated monolayer cultures of pGCs were subj
ected to Western immunoblotting analysis using monoclonal antibodies t
o ERK1, ERK2 and pan-specific ERK. MAP kinases were detected having mo
l wts of 87K (ERK87), 54K (ERK54), 44K (ERK1), and 42K (ERK2). Treatme
nt of pGCs with increasing concentrations (1-10 ng/ml) of EGF for 10 m
in resulted in electrophoretic mobility shifts of ERK1 and ERK2 sugges
ting hyperphosphorylation. Immunoprecipitation with an antiphosphotyro
sine antibody (PY20), followed by Western analysis using pan-ERK, reve
aled a marked concentration-dependent increase in tyrosine phosphoryla
tion of ERK2 in response to EGF treatment. The mobility shift and tyro
sine phosphorylation of ERK2 was observed as early as 1 min after trea
tment with 10 ng/ml EGF. In-gel myelin basic protein (MBP) kinase assa
ys revealed significant MBP kinase activity associated with ERK1 and E
RK2 in total cell lysates and ERK2 in PY20 immunoprecipitates. Althoug
h ERK1 displayed a moderate mobility shift in response to EGF, tyrosin
e phosphorylation of this MAP kinase was not appreciably increased by
EGF. Furthermore, PY20 immunoprecipitates demonstrated minimal MBP kin
ase associated with ERK1 in response to EGF treatment. Electrophoretic
migration, tyrosine phosphorylation, and MBP kinase activity of the E
RK54 and ERK87 was not effected regardless of EGF concentration or dur
ation of treatment. These data demonstrate for the first time that pGC
s contain immunodetectable MAP kinases. EGF, in a concentration- and t
ime-dependent manner, increases tyrosine phosphorylation and MBP kinas
e activity (i.e. activation) of ERK2, and to a lesser degree ERK1, sug
gesting that the activation of MAP kinase may mediate the mitogenic ac
tion of EGF in pGCs.